200
Participants
Start Date
April 4, 2017
Primary Completion Date
December 31, 2022
Study Completion Date
December 31, 2025
Ertapenem followed by levofloxacin and metronidazole
Ertapenem 1 g i.v. daily for either 2 days (MAPPAC + APPAC II patients) or 3 days (MAPPAC + APPAC III) followed by p.o. levofloxacin 500 mg x 1 + metronidazole 500 mg x 3 for either 5 days (APPAC II + MAPPAC) or 4 days (APPAC III + MAPPAC)
Moxifloxacin
Moxifloxacin 400 mg once a day for seven days (APPAC II + MAPPAC)
Appendectomy
Primarily laparoscopic appendectomy for either complicated acute appendicitis or uncomplicated acute appendicitis (refusing to participate in APPAC II or III trials or recurrent acute appendicitis).
Placebo
Placebo i.v. once a day for three days (APPAC III + MAPPAC) followed by placebo capsules three times a day for four days.
Turku University Hospital, Turku
Tampere University Hospital
OTHER
Oulu University Hospital
OTHER
Kuopio University Hospital
OTHER
Helsinki University Central Hospital
OTHER
Jyväskylä Central Hospital
OTHER
Turku University Hospital
OTHER_GOV